Document Detail


Randomized controlled trial of zinc supplementation for persistent diarrhea in adults with HIV-1 infection.
MedLine Citation:
PMID:  16940855     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: In children, zinc supplementation reduces the incidence and severity of diarrhea. METHODS: HIV-infected adults with > or =7 days of diarrhea recruited at 3 tertiary hospitals in Lima, Peru, received a zinc sulfate capsule containing 50 mg of elemental zinc twice daily or an identical placebo for 14 days. Outcomes included persistence of diarrhea at day 14 and time until cessation of diarrhea. RESULTS: The 81 subjects randomized to zinc and 78 randomized to placebo were comparable at baseline, except for higher prevalences of certain enteric pathogens in the zinc group; complete follow-up rates were 62% and 69%, respectively. Zinc concentrations were consistent with zinc deficiency at follow-up in 94% of placebo recipients and 66% of zinc recipients (P = 0.01). Persistence of diarrhea at day 14 according to follow-up interview (60% for zinc-treated patients and 57.4% for placebo-treated patients) or to patient diary (42.2% vs. 31.9%) did not differ significantly. Adjusting for enteric pathogens and CD4 count, the hazard ratio (HR) for zinc supplementation and cessation of diarrhea (according to the diaries) was 0.91 (95% confidence interval [CI]: 0.50 to 1.64). CONCLUSION: Supplemental zinc had no significant effect on the duration or remission of diarrhea in HIV-infected adults.
Authors:
César Cárcamo; Thomas Hooton; Noel S Weiss; Robert Gilman; Mark H Wener; Victor Chavez; Rosario Meneses; Juan Echevarria; Margot Vidal; King K Holmes
Related Documents :
10974985 - Royal society of tropical medicine and hygiene meeting at manson house, london, 18 marc...
2384505 - Clostridium difficile infection in orthopaedic patients.
10423065 - Comparison of intestinal function in human immunodeficiency virus-seropositive patients...
16282305 - Effect of home-based water chlorination and safe storage on diarrhea among persons with...
23205515 - Religious leaders as potential advocates for hiv/aids prevention among the general popu...
12596975 - A study of 235 cases of human brucellosis in sana'a, republic of yemen.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of acquired immune deficiency syndromes (1999)     Volume:  43     ISSN:  1525-4135     ISO Abbreviation:  J. Acquir. Immune Defic. Syndr.     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-09-27     Completed Date:  2006-11-28     Revised Date:  2007-12-03    
Medline Journal Info:
Nlm Unique ID:  100892005     Medline TA:  J Acquir Immune Defic Syndr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  197-201     Citation Subset:  IM; X    
Affiliation:
Department of Epidemiology, University of Washington, Seattle, WA 98104, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Diarrhea / drug therapy*,  epidemiology,  etiology
Dietary Supplements
Drug Administration Schedule
Female
HIV Infections / complications*
Humans
Male
Middle Aged
Outcome Assessment (Health Care)
Placebos
Zinc / administration & dosage,  deficiency,  therapeutic use*
Grant Support
ID/Acronym/Agency:
D43 TW00007-06/TW/FIC NIH HHS
Chemical
Reg. No./Substance:
0/Placebos; 7440-66-6/Zinc

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Validation of primary CD4 gating as an affordable strategy for absolute CD4 counting in Cambodia.
Next Document:  Pregnant women with HIV infection can expect healthy survival: three-year follow-up.